ClinicalTrials.gg
Not yet recruitingNCT07472894PeerMentorAnxDUpdated Apr 14, 2026

AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR ANXIETY AND DEPRESSION PRIMARY PREVENTION IN YOUTH

An interventional study of Peer-mentoring behavioral intervention and Health Education in Anxiety Depression, sponsored by University of Patras. Not yet recruiting at 2 sites in 2 countries. Open to participants aged 12 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-14.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Patras · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,680
Allocation
Randomized
Ages
12 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Depression with a site in Greece — 12 open to participants now, 14 under way, 4 of them phase 3. Depression · Greece.

Planned enrollment
Largest of 20
1,680 · median 285
Started
2027
the only one that year
No phase
12 of 28
6 open now
Primary completion
2028-12
later than 12 of 13 live
Registered
26th of 28
by date

Among the 28 studies in Depression with a site in Greece, this one has the largest planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2027, is one of 12 with no phase, reaches primary completion later than 12 of the 13 other live ones, and was the 26th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

12 of the 28 studies in Depression with a site in Greece are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 12 Years to 25 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Depression with a site in Greece, or all of them as a file.
02

Study summary

The goal of this clinical trial will be to evaluate the efficacy of an AI-informed peer-mentoring program to improve stress management and social skills and reduce the risk of depressive and anxiety symptoms in healthy adolescents (12-18 years old) and young adults (18-25 years old). The main question it aims to answer is whether the peer-mentoring behavioral intervention will achieve the desired behavioral changes and reduce the emergence of anxiety and depression symptoms. Researchers will compare the AI-informed peer-mentoring behavioral intervention program with a standard peer-mentoring program and a standard health educational program. Some study participants will be trained to be peer mentors and subsequently they will be paired with slightly younger mentees and they will attend shared activities for an academic year

Read the detailed description

Adolescence and young adulthood (12-25 years) represent critical developmental periods during which lifestyle patterns related to nutrition, physical activity, sleep, digital media use, social interaction, and stress regulation are consolidated and often persist into adulthood. Preventive interventions targeting these stages therefore offer substantial potential for long-term reduction of non-communicable disease (NCD) burden.

Although young people are often perceived as generally healthy, epidemiological evidence indicates a growing burden of NCD-related conditions in this population. More specifically, in terms of mental health conditions, anxiety and depressive disorders have risen sharply during the last decades, with depression rates among young people increasing by approximately 50% since 1990, contributing to impaired quality of life and increased risk of comorbid physical health problems. A substantial body of evidence links anxiety and depression risk to modifiable lifestyle and psychosocial behaviours established early in life, and behavioural interventions addressing these factors have demonstrated promising effects in young populations. However, existing interventions often show wide variability in design and outcomes and face persistent challenges related to long-term adherence, scalability, and equitable access. Many rely on professional-led delivery models requiring substantial human and financial resources, limiting their sustainability and reach, particularly in low-resource or geographically remote settings.

Digital health interventions have emerged as a promising means to improve accessibility and engagement while supporting self-monitoring and feedback. Digital approaches have demonstrated positive effects on behaviours related to physical activity, diet, sleep and stress management. Nevertheless, many digital interventions remain largely individualised and screen-centric, insufficiently leveraging the social environments in which young people's behaviours are embedded, which may limit sustained engagement and long-term behaviour change.

In this context, peer mentoring represents a promising, yet, underutilised approach for strengthening behavioural self-management and primary NCD prevention among adolescents and young adults. Peer mentoring involves structured, supportive relationships in which individuals with shared or similar lived experiences provide guidance, encouragement, and role modelling. During adolescence and young adulthood, peers exert a strong influence on attitudes, norms, motivation, and behaviour. Peer-led approaches are often perceived as more relatable, credible, and emotionally safe than authority- or expert-led interventions, fostering trust, social connectedness, and intrinsic motivation. Peer mentoring programmes have demonstrated effectiveness in promoting healthy behaviours and psychosocial outcomes in youth, particularly in school-based and community settings.

Peer mentoring aligns closely with contemporary self-management models by promoting active participation, shared responsibility, and empowerment rather than passive receipt of advice. In the context of NCD prevention, it can support the adoption and maintenance of health-promoting behaviours by embedding behaviour change within everyday social interactions and reinforcing positive social norms. Importantly, peer mentoring complements professional care, extending the reach and sustainability of preventive interventions.

In this context, the present clinical trial aims to evaluate the efficacy of a behavioral intervention program to prevent the development of anxiety and depressive disorders in young people aged 12-25 by promoting sustained health-protective behaviours through structured peer mentoring, supported by non-invasive digital technologies and AI-enabled personalisation . The intervention focuses on improving stress management and enhancing social competence and engagement thus proactively empowering young people to self-manage behavioural risk factors before they evolve into long-term health conditions. The AI-informed peer-mentoring intervention will be compared to standard peer mentoring and health educational intervention.

03

Conditions studied

  • Anxiety Depression

Browse trials for

Keywords

  • Anxiety
  • Depression
  • Primary prevention
  • Peer-mentoring
  • Behavioral Intervention
04

In context

Depression Reclassified

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

This study's planned enrollment of 1,680 is above the median of 81 across 7,089 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Patras is the lead sponsor of 70 studies on the registry; 10 are open to participants now.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
12 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Healthy individuals aged 12-25 yrs old -

Exclusion Criteria: Chronic mental health conditions, severe cognitive or communication deficits

-

06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,680 participants (estimated)

Study arms

  • Experimental
    AI-informed peer-mentoring behavioral intervention

    A structured school-based (adolescents) or campus- or community- based (young adults) behavioral change intervention program delivered through peer-mentoring and supported by AI-informed tools, focusing on stress management and social competence. The intervention' s content will be based on existing evidence-based interventions, namely the Mindfulness-based Stress Reduction program which enhances stress management and the Positive Youth Development Framework which strengthens social and emotional skills and facilitates social competence.

    Behavioral: Peer-mentoring behavioral intervention

  • Active comparator
    Standard peer-mentoring behavioral intervention

    A structured school-based (adolescents) or campus- or community- based (young adults) behavioral change intervention program delivered through peer-mentoring but without AI-support

    Behavioral: Peer-mentoring behavioral intervention

  • Active comparator
    Health educational intervention

    Regular health education sessions delivered by professionals

    Other: Health Education

Interventions

  • BehavioralPeer-mentoring behavioral intervention

    The intervention' s content will be based on existing evidence-based interventions, namely the Mindfulness-based Stress Reduction program which enhances stress management and the Positive Youth Development Framework which strengthens social and emotional skills and facilitates social competence.

  • OtherHealth Education

    Health education sessions delivered by professionals focusing on stress management and social skills

07

What researchers measure

Primary outcomes

  1. Perceived Stress Scale (PSS-10)

    Assessment of stress levels

    Time frame: From enrollment to the end of the intervention at 6 months

  2. Revised Children Anxiety and Depression Scale (RCADS-25)

    Assessment of anxiety and depressive symptoms in adolescents

    Time frame: From enrollment to intervention completion at 6 months

  3. Depression Anxiety Stress Scale (DASS-21)

    Assessment of anxiety, depressive and stress symptoms in young adults

    Time frame: From enrollment to study completion at 6 months

  4. Depression Anxiety Stress Scale Youth (DASS-Y)

    Assessment of anxiety, depressive and stress symptoms in adolescents

    Time frame: From enrollment to study completion at 6 months

  5. KIDSCREEN-27 Social functioning sub-scale

    Assessment of social functioning

    Time frame: From enrollment to study completion at 6 months

  6. SF36 Social functioning sub-scale

    Assessment of social functioning

    Time frame: From enrollment to study completion at 6 months

Secondary outcomes

  1. KIDSCREEN-27

    Assessment of quality of life in adolescents

    Time frame: From enrollment to intervention completion at 6 months

  2. Salivary cortisol levels

    Assessment of HPA activity

    Time frame: From enrollment to intervention completion at 6 months

  3. Screen-time self-reported questionnaire

    Assessment of screen-time

    Time frame: From enrollment to intervention completion at 6 months

  4. Pittsburgh Sleep Quality Index AYA version

    Assessment of sleep quality

    Time frame: From enrollment to intervention completion at 6 months

  5. Screen-time mobile tracking device

    Assessment of screen-time

    Time frame: From enrollment to study completion at 6 months

  6. Sleep actigraphic data

    Assessment of sleep parameters with the use of an accelerometer

    Time frame: From enrollment to study completion at 6 months

  7. Five Facet Mindfulness Questionnaire Short Form

    It measures the 5 facets of mindfulness

    Time frame: From study enrollment to study completion at 12 months

08

Study locations

2 sites
09

References and documents

Individual participant data

Plan to share: Yes — IPD will be anonymized and will be entered in databases available to researchers

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: After publication of study results

Access criteria: Researchers

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2027; primary completion for Dec 2028, 15 months later.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 15 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2026
First posted
Mar 16, 2026
StartEst.
Sep 1, 2027
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Apr 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07472894
Lead sponsor
University of Patras
Collaborators
Modena Health Authority, University of Bologna, 6th Hellenic Health District
Responsible party
Aikaterini Karaivazoglou (Assistant Professor of Child and Adolescent Psychiatry, University of Patras) — Principal investigator
First posted
Mar 16, 2026
Start date
Sep 1, 2027 (estimated)
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Apr 14, 2026

Study contacts

Aikaterini Karaivazoglou, PhD
Contact
karaivaz@hotmail.com
00306977711259

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion